Maria E. SantolayaTHOMPSON MOYA, LUIS ADALBERTOLUIS ADALBERTOTHOMPSON MOYADona BenadofCecilia TapiaClaudia CortésLEGARRAGA RADDATZ, PAULETTEPAULETTELEGARRAGA RADDATZMarcela RabelloRomina ValenzuelaPamela RojasRicardo Rabagliati2022-09-232022-09-232019http://hdl.handle.net/11447/6290https://investigadores.udd.cl/handle/123456789/250810.1371/journal.pone.02129242-s2.0-85062618303WOS:000460640900015invasive candidiasisactive surveillancefungal-infectionsepidemiologymanagementrecommendationschildrenpredictorshospitalsoutcomesadolescentadultagedcandidacandidemiachildchileepidemiological monitoringfemalehumansincidencemalemiddle agedprospective studiessurvival rateyoung adultamphotericin b deoxycholateamphotericin b lipid complexanidulafunginantibiotic agentcaspofunginechinocandinfluconazoleitraconazolemicafunginvoriconazoleadultagedantifungal resistanceantifungal susceptibilityarticlebloodstream infectioncandida albicanscandida glabratacandida parapsilosiscandida tropicaliscandidemiachildchileclinical featurecontrolled studydemographyfemalefungal straingroups by agehealth surveyhospital admissionhumanincidenceinfantinfection risklaboratory testmajor clinical studymaleminimum inhibitory concentrationmulticenter study (topic)newbornnonhumanobservational studyoverall survivalpediatric patientpopulation researchprospective studyspecies differencespecies distributionstrain identificationtertiary care centeradolescentcandidacandidemiaclinical trialepidemiological monitoringisolation and purificationmicrobiologymiddle agedmulticenter studysurvival rateyoung adultResource Types::text::journal::journal article